WGS is trading at $71.62 (6.09% up) as the stock continues to rebound following a volatile stretch and a pullback on July 2.
- The upward move appears largely tied to momentum and broader biotech-style volatility rather than a clearly identified new company-specific catalyst.
- GeneDx remains in the news regarding a securities class action tied to its May 4 earnings and Fabric Genomics disclosure, though no new announcements explain the July 6 jump.
- The current price action follows a prior session rebound, marking a recovery from recent downward pressure.